Disruption and Regulation
Anne discusses the challenges 23andMe faced with the medical community and the FDA, highlighting the tension between innovation and regulation. While the company aimed to empower consumers with genetic information, they encountered significant pushback from traditional healthcare practices. The narrative reveals the complexities of navigating both consumer needs and regulatory landscapes, emphasizing that disruption often comes with its own set of hurdles.In this clip
From this podcast
Masters of Scale
23andMe's Anne Wojcicki: Embrace the gatekeepers
Related Questions
Tell me about 23andMe as discussed in the episode 23andMe's Anne Wojcicki: Embrace the gatekeepers and the clip Disruption and Regulation
What is the main topic of the clip Navigating FDA Challenges from the episode 23andMe's Anne Wojcicki: Embrace the gatekeepers?
What is your opinion on 23andMe as discussed in the episode 23andMe's Anne Wojcicki: Embrace the gatekeepers and the clip Direct Access Debate?